Policy empowers the pharmaceutical industry to improve quality and upgrade. Zhendong Pharmacy strengthens its foundation and explores new multidimensional layouts to move forward steadily同壁财经·May 25 at 01:11 AM300158+1.44%
00:35 ETSky Labs bringt „CART ON" auf den Markt, die weltweit erste ringförmige, tragbare Blutdrucküberwachungslösung für Krankenhausabteilungenprnewswire·Feb 9 at 11:38 PM513700+0.35%XBI-2.31%
Zhendong Pharmacy established a refined wall-breaking decoction pieces technology companyZhitong·Oct 27, 2025 at 10:16 PM300158+1.44%
Zhendong Pharmacy released its performance for the first three quarters, with a net profit attributable to the parent company of 20.3641 million yuan, a decrease of 49.25%Zhitong·Oct 22, 2025 at 07:56 AM300158+1.44%
Innovative drug concept stocks fell in the afternoon, with Staidson BioPharm down over 10%Zhitong·Sep 2, 2025 at 12:17 AM002940+3.97%300158+1.44%
Zhendong Pharmacy: Adjusting the upper limit of the repurchase price to RMB 11.40 per shareZhitong·Aug 25, 2025 at 03:14 AM300158+1.44%
The A-share traditional Chinese medicine sector rapidly surged, with Xintian Pharma hitting the limit up, and YIBAI PHARMACEUTICAL, Zhendong Pharmacy, ZHONGSHENGYAOYE, Hansen Pharmaceutical, and ENWEI PHARMACEUTICAL following suitZhitong·Aug 24, 2025 at 08:52 PM301331+3.88%002873+2.54%
The traditional Chinese medicine concept continues to strengthen, with Layn hitting the daily limit, and companies such as Zhongsheng Pharmaceutical, Kanion Pharmaceutical, JINGXIN, Zhendong Pharmacy, CONBA, and Chase Sun also risingZhitong·Aug 11, 2025 at 08:36 PM600572+0.46%300026+0.60%
A-share pharmaceutical stocks continue to adjust, CheezhengTTM approaches the limit down, and multiple stocks such as Xintian Pharmaceutical, Hanyu Pharmaceutical, Guilin Sanjin, Foci Pharmaceutical, YIBAI PHARMACEUTICAL, Zhendong Pharmacy, and Cosunter have fallen over 5%Wallstreetcn·Aug 6, 2025 at 01:41 AM300158+1.44%002287+0.38%
Zhendong Pharmacy: The company has no drugs available for the treatment of Chikungunya virusZhitong·Jul 30, 2025 at 10:59 PM300158+1.44%
Zhendong Pharmacy: Vaginal Lactobacillus Dual Live Bacteria Capsules Achieve Primary Research EndpointZhitong·Jul 30, 2025 at 06:45 AM300158+1.44%
Zhendong Pharmacy: Controlling shareholder pledges 0.73% of the company's sharesZhitong·Jul 18, 2025 at 05:25 AM300158+1.44%
Innovative drugs and CRO concept stocks strengthen again, Sunshine Guojian Pharmaceutical rises over 10%Zhitong·May 26, 2025 at 09:00 PM002099+0.37%688336+3.61%
Zhendong Pharmacy invests in Shanxi to establish a large pharmacy companyZhitong·Apr 23, 2025 at 02:16 AM300158+1.44%
Zhendong Pharmacy released its 2024 annual performance, with a net loss attributable to the parent company of 1.329 billion yuanZhitong·Apr 20, 2025 at 04:14 AM300158+1.44%
